SEC Form 4 · accession 0001230724-26-000014
Vaxcyte, Inc. · PCVX
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Andrew Guggenhime
Officer — PRESIDENT AND CFO
Period of report
Aug 3, 2026
Accepted (ET)
Aug 5, 2026 · 4:58 pm EDT
Rule 10b5-1 plan
yes — trade under a plan
Issuer CIK
0001649094
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1 | Aug 3, 2026 | M | 10,000 | $5.35 | A | 115,176 | D | |
| Common StockF3 | Aug 3, 2026 | S | 6,956 | $53.761 | D | 108,220 | D | |
| Common StockF4 | Aug 3, 2026 | S | 3,044 | $54.178 | D | 105,176 | D | |
| Common StockF5 | holding | — | — | — | 61,850 | I | See Footnote |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (right to buy)F6 | $5.35 | Aug 3, 2026 | M | 10,000 | D | — | May 11, 2030 | Common Stock | 10,000 | 216,827 | D |
Explanation of responses
- F1Includes 781 shares acquired under the Issuer's Employee Stock Purchase Plan on May 15, 2026.
- F2The sale reported on this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted March 4, 2026.
- F3The price reported is a weighted-average price. The shares were sold at prices ranging from $53.06 to $54.05. The reporting person will provide upon request to the SEC, the issuer or security holder of the issuer, full information regarding the number of shares sold at each separate price.
- F4The price reported is a weighted-average price. The shares were sold at prices ranging from $54.07 to $54.44. The reporting person will provide upon request to the SEC, the issuer or security holder of the issuer, full information regarding the number of shares sold at each separate price.
- F5Shares are held by ALG 2025 GRAT HOLDINGS LLC, of which 100% of the limited liability company interest is owned by a grantor retained annuity trust, of which the Reporting Person is the annuitant and the trustee.
- F6Option is fully vested and exercisable.